Groove Botanicals, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

For the Three Months Ended

June 30,

2022

2021

Cash Flow From Operating Activities

Net Income (Loss)

$

48,412

$

186,819

Adjustments to reconcile net loss to net cash used in

operating activities:

Amortization of Debt Discount

19,979

9,973

Change in Derivative Liability

(88,284)

(214,146)

Effect of Debt Discounts on Derivative Liability

-

100,126

Effect of Valuation Adjustments on Debt Discounts

-

(104,650)

Gain on Settlement of Debt

(25,000)

(52,458)

Accrued Interest

3,960

3,156

Accrued Payroll

12,000

12,000

Reimbursable Expenses due to Related Party

80

-

Changes in working capital

Decrease in Accounts Receivable

210

-

Decrease in Prepaid Expenses

-

50,000

Increase (Decrease) in Accounts Payable and Accrued Liabilities

(170)

972

Net Cash Used in Operating Activities

(28,812)

(8,207)

Cash Flow From Investing Activities

Net Cash From Investing Activities

-

-

Cash Flow From Financing Activities

Funds received from Related Party

125,000

500

Funds distributed to Related Party

(4,000)

-

Repayment of Outstanding Convertible Debt

(59,650)

-

Repayment of Outstanding Contingent Liability

(70,350)

-

Net Cash From Financing Activities

(9,000)

500

Net Change in Cash

(37,812)

(7,707)

Cash at Beginning of Period

48,534

7,911

Cash at End of Period

$

10,721

$

204

Net cash paid for:

Interest

$

-

$

-

Income Taxes

$

-

$

-

The accompanying notes are an integral part of these unaudited consolidated financial statements

Groove Botanicals, Inc.

Consolidated Balance Sheets

(Unaudited)

June 30,

March 31,

2022

2022

ASSETS

Current Assets:

Cash and Cash Equivalents

$

10,721

$

48,534

Accounts Receivable

41

251

Total Current Assets

10,762

48,785

TOTAL ASSETS

$

10,762

$

48,785

LIABILITIES & STOCKHOLDERS' EQUITY

Current Liabilities:

Accounts Payable and Accrued Liabilities

$

45,421

$

45,592

Interest Payable

11,860

7,900

Related Party Payable

227,608

94,528

Convertible Notes Payable

125,104

164,774

Derivative Liability

7,292

95,576

Contingent Liability

-

95,350

Total Current Liabilities

417,285

503,720

Total Liabilities

417,285

503,720

Stockholders' Equity

Preferred Stock, Series A, $0.10 par value, 100 shares

10

10

authorized; 100 shares issued and outstanding as of

June 30, 2022, and March 31, 2022, respectively

Preferred Stock, Series B, $0.10 par value, 2,000

198

198

shares authorized; 1,983 shares issued and outstanding as

of June 30, 2022, and March 31, 2022, respectively

Common Stock, $0.001 par value, 200,000,000 shares

52,193

49,193

authorized; 52,193,062 and 49,193,062 shares issued

and outstanding as of June 30, 2022 and

March 31, 2022, respectively

Common Stock to be Issued

-

3,000

Additional paid-in capital

34,023,506

34,023,506

Accumulated deficit

(34,482,430)

(34,530,842)

Total stockholder's equity

(406,523)

(454,935)

TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT

$

10,762

$

48,785

The accompanying notes are an integral part of these unaudited consolidated financial statements

Groove Botanicals, Inc.

Consolidated Statements of Stockholders' Equity

For the Three Months Ended June 30, 2022, and the Three Years Ended March 31, 2022, 2021, and 2020

(Unaudited)

Additional

Paid In

Accumulated

Series A Preferred Stock

Series B Preferred Stock

Common Stock

Common Stock to be Issued

Capital

Deficit

Total

Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Amount

Amount

Amount

Balance, March 31, 2019

100

$

10

1,983

$

198

29,393,062

$

29,393

-

$

-

$

33,003,441

$

(33,530,939)

$

(497,897)

Net Loss

-

-

-

-

-

-

-

-

-

(142,995)

(142,995)

Balance, March 31, 2020

100

$

10

1,983

$

198

29,393,062

$

29,393

-

$

-

$

33,003,441

$

(33,673,934)

$

(640,892)

Balance, March 31, 2020

100

$

10

1,983

$

198

29,393,062

$

29,393

-

$

-

$

33,003,441

$

(33,673,934)

$

(640,892)

Issuance of stock for services

-

-

-

-

5,400,000

5,400

-

-

357,450

-

362,850

Issuance of stock per subscription

-

-

-

-

3,000,000

3,000

-

-

146,965

-

149,965

Beneficial Conversion Feature

-

-

-

-

-

-

-

-

40,000

-

40,000

Net Loss

-

-

-

-

-

-

-

-

-

(434,449)

(434,449)

Balance, March 31, 2021

100

$

10

1,983

$

198

37,793,062

$

37,793

-

$

-

$

33,547,856

$

(34,108,384)

$

(522,527)

Balance, March 31, 2021

100

$

10

1,983

$

198

37,793,062

$

37,793

-

$

-

$

33,547,856

$

(34,108,384)

$

(522,527)

Issuance of Stock for Director Compensation

-

-

-

-

1,000,000

1,000

-

-

49,000

-

50,000

Issuance of Stock for Outside Services

-

-

-

-

6,650,000

6,650

-

-

216,350

-

223,000

Issuance of Stock for Settlement

-

-

-

-

1,000,000

1,000

-

-

31,000

-

32,000

Issuance of Stock per Subscription

-

-

-

-

2,750,000

2,750

-

-

52,300

-

55,050

Beneficial Conversion Feature

-

-

-

-

-

-

-

-

80,000

-

80,000

Common Stock to be Issued

-

-

-

-

-

-

3,000,000

3,000

47,000

-

50,000

Net Loss

-

-

-

-

-

-

-

-

-

(422,458)

(422,458)

Balance, March 31, 2022

100

$

10

1,983

$

198

49,193,062

$

49,193

3,000,000

$

3,000

$

34,023,506

$

(34,530,842)

$

(454,935)

Balance, March 31, 2022

100

$

10

1,983

$

198

49,193,062

$

49,193

3,000,000

$

3,000

$

34,023,506

$

(34,530,842)

$

(454,935)

Issuance of Stock per Subscription

-

-

-

-

3,000,000

3,000

-

(3,000)

-

-

-

Net Income

-

-

-

-

-

-

-

-

-

48,412

48,412

Balance, June 30, 2022

100

$

10

1,983

$

198

52,193,062

$

52,193

3,000,000

$

-

$

34,023,506

$

(34,482,430)

$

(406,523)

The accompanying notes are an integral part of these unaudited consolidated financial statements

Groove Botanicals, Inc.

Consolidated Statements of Operations

(Unaudited)

For the Three Months Ended

2022

June 30,

2021

Oil and Gas Sales

$

221

$

6,576

Cost of Goods Sold

-

-

Gross Profit

221

6,576

Expenses:

Selling, General and Administrative Expenses

18,598

25,699

Rent

3,927

1,200

Bank Service Charges

70

120

Legal and Professional Expenses

18,558

972

Total Operating Expenses

41,153

27,992

Operating Loss

(40,932)

(21,416)

Other Income (Expense)

Amortization of Debt Discount

(19,979)

(9,973)

Change in Derivative Liability

88,284

214,146

Gain on Settlement of Debt

25,000

52,458

Interest Expense

(3,960)

(48,632)

Miscellaneous Other Income

-

235

Total Other Income

89,344

208,235

Net Income

$

48,412

$

186,819

Basic and Diluted Earnings per Common Share

$

0.00

$

0.00

Weighted Average Common Shares Outstanding

51,929,326

37,793,062

The accompanying notes are an integral part of these unaudited consolidated financial statements

Groove Botanicals, Inc.

Notes to the Consolidated Financial Statements

For the quarters ended June 30, 2022, and 2021

NOTE 1 - ORGANIZATION AND OPERATIONS

Current Operations

Groove Botanicals ("GRVE" or the "Company" or the "Corporation"), a Nevada corporation, is a publicly quoted independent oil and gas producer.

Corporate History

Groove Botanicals, Inc. (the "Company"), (formerly known as Avalon Oil & Gas, Inc.), was originally incorporated in Colorado in April 1991 under the name Snow Runner (USA), Inc. The Company was the general partner of Snow Runner (USA) Ltd.; a Colorado limited partnership to sell proprietary snow skates under the name "Sled Dogs" which was dissolved in August 1992. In late 1993, the Company relocated its operations to Minnesota and in January 1994 changed our name to Snow Runner, Inc. In November 1994 we changed our name to the Sled Dogs Company

In May 1999, we changed our state of domicile to Nevada and our name to XDOGS.COM, Inc. On July 31, 1998, the Corporation split their shares One (1) for Fifty-Four (54).

On August 24, 2000, the Corporation split their shares One (1) for Five (5) and changed our name from XDOGS.COM to XDOGS, Inc. We changed our symbol from XDGS to XDGI.

On June 22, 2005, the Corporation changed our name from XDOGS, Inc. to Avalon Oil and Gas, Inc. We changed our symbol from XDGI to AOGS.

On July 22, 2005, the Board of Directors and a majority of the Company's shareholders approved an amendment to our Articles of Incorporation to change the Company's name to Avalon Oil & Gas, Inc., and to increase the authorized number of shares of our common stock from 200,000,000 shares to 1,000,000,000 shares par value of $0.001.

On May 15, 2007, the Corporation split their shares One (1) for Twenty (20). We changed our symbol from AOGS to AOGN.

On June 4, 2012, the Board of Directors approved an amendment to our Articles of Incorporation to a reverse split of the issued and outstanding shares of Common Stock of the Corporation ("Shares") such that each holder of Shares as of the record date of June 4, 2012 shall receive one (1) post-split Share on the effective date of June 4, 2012 for each three hundred (300) Shares owned. The reverse split was effective on July 23, 2012.

On September 28, 2012, we held a special meeting of Avalon's shareholders and approved an amendment to the Company's Articles of Incorporation such that the Company would be authorized to issue up to 200,000,000 shares of common stock. We filed an amendment with the Nevada Secretary of State on April 10, 2013, to increase our authorized shares to 200,000,000.

On July 23, 2012, the Corporation split their shares One (1) for Three Hundred (300).

On May 14, 2018, the Corporation changed our name from Avalon Oil and Gas, Inc., to Groove Botanicals, Inc. We changed our symbol from AOGN to GRVE.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United Stated of America ("U.S. GAAP") for interim unaudited financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited financial statements include all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary in order to make the condensed financial statements not misleading. Notes to the financial statements which

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Groove Botanicals Inc. published this content on 16 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 August 2022 01:31:07 UTC.